The T-box transcription factor eomesodermin controls CD8 T cell activily and lymph node metastasis in human colorectal cancer

Atreya, Imke; Schimanski, Carl C.; Becker, Christoph; Wirtz, Stefan; Dornhoff, Heike; Schnürer, Elke; Berger, Martin R.; Galle, Peter R.; Herr, Wolfgang; Neurath, Markus F.
November 2007
Gut;Nov2007, Vol. 56 Issue 11, p1572
Academic Journal
Background/aims: An efficient cytolytic T cell function is essential for immune mediated rejection of colorectal cancer. However, the molecular mechanisms driving T cell mediated cancer rejection are still poorly understood. Here, we assessed the relevance of the T-box transcription factor eomesodermin in colorectal cancer. Methods/results: By analysing tissue probes from 88 different colorectal tumours, a significant (p<0.02) inverse correlation between eomesodermin expression in colorectal cancers and the presence of lymph node metastases could be shown, whereas no such correlation was noted for the master transcription factor of regulatory T cells, FoxP3 and CD8alpha expression. To evaluate whether this effect might be due to effects of eomesodermin on tumour infiltrating CD8 T cells, we subsequently analysed the regulated expression and function of this transcription factor in human T cells. Whereas overexpression of this factor induced perform but not granzyme expression, siRNA mediated suppression of eomesodermin expression led to significantly reduced IFN-γ production, perform levels and cytolytic activity of CD8 T cells. Furthermore, TGF-β and IL4 could be identified as important inducer of eomesodermin expression. Conclusion: These data define for the first time a regulatory role of eomesodermin for CD8 T cell activity in humans. Our findings are consistent with a model in which eomesodermin expression in tumour infiltrating T cells regulates cytolytic functions of CD8 T cells via perform expression. These data provide novel insights into control mechanisms governing the functional activity of human CD8 T lymphocytes via T-box transcription factors in cancer.


Related Articles

  • Tumor immunosurveillance in human cancers. Mlecnik, Bernhard; Bindea, Gabriela; Pagès, Franck; Galon, Jérôme // Cancer & Metastasis Reviews;Mar2011, Vol. 30 Issue 1, p5 

    Until now, the anatomic extent of tumor (TNM classification) has been by far the most important factor to predict the prognosis of colorectal cancer patients. However, in recent years, data collected from large cohorts of human cancers demonstrated that the immune contexture of the primary...

  • B Cells and Ectopic Follicular Structures: Novel Players in Anti-Tumor Programming with Prognostic Power for Patients with Metastatic Colorectal Cancer. Meshcheryakova, Anastasia; Tamandl, Dietmar; Bajna, Erika; Stift, Judith; Mittlboeck, Martina; Svoboda, Martin; Heiden, Denise; Stremitzer, Stefan; Jensen-Jarolim, Erika; Grünberger, Thomas; Bergmann, Michael; Mechtcheriakova, Diana // PLoS ONE;Jun2014, Vol. 9 Issue 6, p1 

    Remarkably limited information is available about biological mechanisms that determine the disease entity of metastatic colorectal cancer in the liver (CRCLM) with no good clinical parameters to estimate prognosis. For the last few years, understanding the relationship between tumor...

  • Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells. Simms, Neka A.K.; Rajput, Ashwani; Sharratt, Elizabeth A.; Ongchin, Melanie; Teggart, Carol A.; Wang, Jing; Brattain, Michael G. // BMC Cancer;2012, Vol. 12 Issue 1, p221 

    Background: TGFβ signaling has typically been associated with suppression of tumor initiation while the role it plays in metastasis is generally associated with progression of malignancy. However, we present evidence here for an anti-metastatic role of TGFβ signaling. Methods: To test the...

  • The Surgical Treatment of Hepatic Metastases in Colorectal Carcinoma. Neumann, Ulf Peter; Seehofer, Daniel; Neuhaus, Peter // Deutsches Aerzteblatt International;5/14/2010, Vol. 107 Issue 19, p2 

    The article presents information on the surgical treatment of hepatic metastases in colorectal carcinoma. It informs that colorectal carcinoma is the most common type of cancer in the world and is the main cause of maximum deaths in Germany. It states that metastases are resectable in the...

  • Immunomodulatory Effects in a Phase II Study of Lenalidomide Combined with Cetuximab in Refractory KRAS-Mutant Metastatic Colorectal Cancer Patients. Gandhi, Anita K.; Shi, Tao; Li, Mingyu; Jungnelius, Ulf; Romano, Alfredo; Tabernero, Josep; Siena, Salvatore; Schafer, Peter H.; Chopra, Rajesh // PLoS ONE;Nov2013, Vol. 8 Issue 11, p1 

    : This study assessed the immunomodulatory effects in previously treated KRAS-mutant metastatic colorectal cancer patients participating in a phase II multicenter, open-label clinical trial receiving lenalidomide alone or lenalidomide plus cetuximab. The main findings show the T cell...

  • Changes of T Cells and Cytokines TGF-β1 and IL-10 in Mice During Liver Metastasis of Colon Carcinoma: Implications for Liver Anti-tumor Immunity. Huang, Xiaoming; Zou, Yifeng; Lian, Lei; Wu, Xiaojian; He, Xiaosheng; He, Xiaowen; Wu, Xianrui; Huang, Yan; Lan, Ping // Journal of Gastrointestinal Surgery;Jul2013, Vol. 17 Issue 7, p1283 

    Background: The local and systemic regulation of the immune system may play important roles in the process of liver metastasis of colorectal carcinoma. The aim of this study was to establish a reproducible experimental liver metastasis model, to identify changes in T cells and cytokines...

  • CD133+CXCR4+ colon cancer cells exhibit metastatic potential and predict poor prognosis of patients. Shan-shan Zhang; Zhi-peng Han; Ying-ying Jing; Shuang-fen Tao; Tie-jun Li; Hao Wang; Yang Wang; Rong Li; Yang Yang; Xue Zhao; Xiao-dong Xu; En-da Yu; Yao-cheng Rui; Hou-jia Liu; Li Zhang; Li-xin Wei // BMC Medicine;2012, Vol. 10 Issue 1, p85 

    Background: Colorectal cancer (CRC), which frequently metastasizes to the liver, is one of the three leading causes of cancer-related deaths worldwide. Growing evidence suggests that a subset of cells exists among cancer stem cells. This distinct subpopulation is thought to contribute to liver...

  • Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer. Zheng JIANG; Zhimin WANG; Ye XU; Beilan WANG; Wei HUANG; Sanjun CAI // Bioscience Reports;Dec2010, Vol. 30 Issue 6, p383 

    The role of RGS2 (regulator of G-protein signalling 2) has been studied in several tumours. The purpose of the present study is to investigate the correlations between clinicopathological factors and patients' survival time and RGS2 expression in stage II and III CRC (colorectal cancer)...

  • Prognostic value of disseminated colorectal tumor cells in the liver: results of follow-up examinations. Linnemann, Ulrich; Schimanski, Christoph C.; Gebhardt, Christoph; Berger, Martin R. // International Journal of Colorectal Disease;Jul2004, Vol. 19 Issue 4, p380 

    Background and aims. Dissemination of tumor cells is an initial step in metastatic disease. Detection of disseminated tumor cells (DTC) in blood, bone marrow and lymph nodes has been associated with reduced disease-free survival, but to date there are no data for hepatic DTC. We investigated the...


Read the Article


Sign out of this library

Other Topics